263 related articles for article (PubMed ID: 19290940)
1. Hydrogenated castor oil nanoparticles as carriers for the subcutaneous administration of tilmicosin: in vitro and in vivo studies.
Han C; Qi CM; Zhao BK; Cao J; Xie SY; Wang SL; Zhou WZ
J Vet Pharmacol Ther; 2009 Apr; 32(2):116-23. PubMed ID: 19290940
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of antibacterial activity of tilmicosin against Staphylococcus aureus by solid lipid nanoparticles in vitro and in vivo.
Wang XF; Zhang SL; Zhu LY; Xie SY; Dong Z; Wang Y; Zhou WZ
Vet J; 2012 Jan; 191(1):115-20. PubMed ID: 21900026
[TBL] [Abstract][Full Text] [Related]
3. Acute toxicity study of tilmicosin-loaded hydrogenated castor oil-solid lipid nanoparticles.
Xie S; Wang F; Wang Y; Zhu L; Dong Z; Wang X; Li X; Zhou W
Part Fibre Toxicol; 2011 Nov; 8():33. PubMed ID: 22098626
[TBL] [Abstract][Full Text] [Related]
4. Preparation and evaluation of tilmicosin-loaded hydrogenated castor oil nanoparticle suspensions of different particle sizes.
Chen X; Wang T; Lu M; Zhu L; Wang Y; Zhou W
Int J Nanomedicine; 2014; 9():2655-64. PubMed ID: 24920902
[TBL] [Abstract][Full Text] [Related]
5. The controlled release of tilmicosin from silica nanoparticles.
Song M; Li Y; Fai C; Cui S; Cui B
Drug Dev Ind Pharm; 2011 Jun; 37(6):714-8. PubMed ID: 21204738
[TBL] [Abstract][Full Text] [Related]
6. Tilmicosin- and florfenicol-loaded hydrogenated castor oil-solid lipid nanoparticles to pigs: Combined antibacterial activities and pharmacokinetics.
Ling Z; Yonghong L; Junfeng L; Li Z; Xianqiang L
J Vet Pharmacol Ther; 2018 Apr; 41(2):307-313. PubMed ID: 29139136
[TBL] [Abstract][Full Text] [Related]
7. Preparation, characterization, and pharmacokinetics of tilmicosin- and florfenicol-loaded hydrogenated castor oil-solid lipid nanoparticles.
Ling Z; Yonghong L; Changqing S; Junfeng L; Li Z; Chunyu J; Xianqiang L
J Vet Pharmacol Ther; 2017 Jun; 40(3):293-303. PubMed ID: 27687707
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the antibacterial activity of tilmicosin-SLN against
Zhu L; Cao X; Xu Q; Su J; Li X; Zhou W
Int J Nanomedicine; 2018; 13():4747-4755. PubMed ID: 30147316
[TBL] [Abstract][Full Text] [Related]
9. Elimination of tilmicosin in lactating ewes.
Atef M; Abo el-Sooud K; Nahed E; Tawfik M
Dtsch Tierarztl Wochenschr; 1999 Jul; 106(7):291-4. PubMed ID: 10481373
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of tilmicosin in beef cattle following intravenous and subcutaneous administration.
Lombardi KR; Portillo T; Hassfurther R; Hunter RP
J Vet Pharmacol Ther; 2011 Dec; 34(6):583-7. PubMed ID: 21323676
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of tilmicosin in equine tissues and plasma.
Clark C; Dowling PM; Ross S; Woodbury M; Boison JO
J Vet Pharmacol Ther; 2008 Feb; 31(1):66-70. PubMed ID: 18177321
[TBL] [Abstract][Full Text] [Related]
12. [In vitro dexamethasone release from nanoparticles and its pharmacokinetics in the inner ear after administration of the drug-loaded nanoparticles via the round window].
Chen G; Hou SX; Hu P; Hu QH; Guo DD; Xiao Y
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jun; 28(6):1022-4. PubMed ID: 18583254
[TBL] [Abstract][Full Text] [Related]
13. Formulation, characterization and pharmacokinetics of praziquantel-loaded hydrogenated castor oil solid lipid nanoparticles.
Xie S; Pan B; Wang M; Zhu L; Wang F; Dong Z; Wang X; Zhou W
Nanomedicine (Lond); 2010 Jul; 5(5):693-701. PubMed ID: 20662641
[TBL] [Abstract][Full Text] [Related]
14. Elimination kinetics of tilmicosin following intramammary administration in lactating dairy cattle.
Smith GW; Davis JL; Baynes RE; Yeatts JL; Barlow BM; Riviere JE
J Am Vet Med Assoc; 2009 Jan; 234(2):245-8. PubMed ID: 19210246
[TBL] [Abstract][Full Text] [Related]
15. The possible protective effect of L-carnitine on tilmicosin-induced cardiotoxicity in mice.
Kart A; Yapar K; Karapehlivan M; Citil M
J Vet Med A Physiol Pathol Clin Med; 2007 Apr; 54(3):144-6. PubMed ID: 17381679
[TBL] [Abstract][Full Text] [Related]
16. Residue depletion of tilmicosin in cattle after subcutaneous administration.
Jiang H; Ding S; Li J; An D; Li C; Shen J
J Agric Food Chem; 2006 Jul; 54(14):5208-13. PubMed ID: 16819937
[TBL] [Abstract][Full Text] [Related]
17. Tilmicosin enteric granules and premix to pigs: Antimicrobial susceptibility testing and comparative pharmacokinetics.
Xiong J; Zhu Q; Zhao Y; Yang S; Cao J; Qiu Y
J Vet Pharmacol Ther; 2019 May; 42(3):336-345. PubMed ID: 30801755
[TBL] [Abstract][Full Text] [Related]
18. Milk and blood pharmacokinetics of tylosin and tilmicosin following parenteral administrations to cows.
Avci T; Elmas M
ScientificWorldJournal; 2014; 2014():869096. PubMed ID: 25177733
[TBL] [Abstract][Full Text] [Related]
19. Final report on the safety assessment of Ricinus Communis (Castor) Seed Oil, Hydrogenated Castor Oil, Glyceryl Ricinoleate, Glyceryl Ricinoleate SE, Ricinoleic Acid, Potassium Ricinoleate, Sodium Ricinoleate, Zinc Ricinoleate, Cetyl Ricinoleate, Ethyl Ricinoleate, Glycol Ricinoleate, Isopropyl Ricinoleate, Methyl Ricinoleate, and Octyldodecyl Ricinoleate.
Int J Toxicol; 2007; 26 Suppl 3():31-77. PubMed ID: 18080873
[TBL] [Abstract][Full Text] [Related]
20. Long-circulation of hemoglobin-loaded polymeric nanoparticles as oxygen carriers with modulated surface charges.
Xu F; Yuan Y; Shan X; Liu C; Tao X; Sheng Y; Zhou H
Int J Pharm; 2009 Jul; 377(1-2):199-206. PubMed ID: 19454305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
